UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...
Systems (NASDAQ: KRMD), a medical technology firm with a market capitalization of $194 million, announced a partnership with a global pharmaceutical manufacturer to conduct a Phase III clinical trial.
Avanos Medical, Inc. AVNS is well-poised for growth in the coming quarters, courtesy of its impressive product line. The optimism, led by a solid fiscal third-quarter 2024 performance and continued ...
The findings provide an important reference to evaluate the quality control of administered infusion solutions. Cytotoxic drugs commonly used in clinical practice were selected from the medical ...
Commissions do not affect our editors' opinions or evaluations. Major medical insurance is comprehensive health insurance that covers medical services, hospitalizations, doctor visits ...